Idiopathic intracranial hypertension

Cephalalgia

Volumn 35, Issue 3, 2015, Pages 248-261

  Wakerley, B R ^a   Tan, M H ^b   Ting, E Y ^c  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b ROYAL PERTH HOSPITAL   (Australia)

^c NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

benign intracranial hypertension; Idiopathic intracranial hypertension; pseudotumour cerebri; raised intracranial pressure

Indexed keywords

ACETAZOLAMIDE; LOOP DIURETIC AGENT; RETINOL;

BRAIN PSEUDOTUMOR; CEREBROSPINAL FLUID; CRANIAL SINUS; DIFFERENTIAL DIAGNOSIS; HUMAN; IDIOPATHIC INTRACRANIAL HYPERTENSION; INCIDENCE; INTRACRANIAL PRESSURE; MICROTHROMBUS; OBESITY; PATHOGENESIS; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; RISK FACTOR; SLEEP DISORDERED BREATHING; VITAMIN METABOLISM; FEMALE; OPTIC NERVE DISEASES; PSEUDOTUMOR CEREBRI; SEX DIFFERENCE;

FEMALE; HUMANS; OBESITY; OPTIC NERVE DISEASES; PSEUDOTUMOR CEREBRI; RISK FACTORS; SEX FACTORS;

EID: 84923933021     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102414534329     Document Type: Review

References (120)

1. Johnston I, Owler B, Pickard J The pseudotumor cerebri syndrome: Pseudotumor cerebri, idiopathic intracranial hypertension, benign intracranial hypertension and related conditions. Cambridge: Cambridge University Press ; 2007: 1-356.
2. Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013 ; 81: 1159-1165
3. Best J, Silvestri G, Burton B, et al. The incidence of blindness due to idiopathic intracranial hypertension in the UK. Open Ophthalmol J. 2013 ; 7: 26-29
4. Radhakrishnan K, Ahlskog JE, Cross SA, et al. Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol. 1993 ; 50: 78-80
5. Raoof N, Sharrack B, Pepper IM, et al. The incidence and prevalence of idiopathic intracranial hypertension in Sheffield, UK. Eur J Neurol. 2011 ; 18: 1266-1268
6. Hamdallah IN, Shamseddeen HN, Getty JL, et al. Greater than expected prevalence of pseudotumor cerebri: A prospective study. Surg Obes Relat Dis. 2013 ; 9: 77-82
7. The Organization for Economic Co-operation and Development (OECD). Obesity and the economics of prevention: Fit not fat - Canada key facts, 2010, http://www.oecd.org/els/healthpoliciesanddata/obesityandtheeconomicsofpreventionfitnotfat-canadakeyfacts.htm (accessed November 2012).
8. Karnik S, Kanekar A. Childhood obesity: A global public health crisis. Int J Prev Med. 2012 ; 3: 1-7
9. Szewka AJ, Bruce BB, Newman NJ, et al. Idiopathic intracranial hypertension: Relation between obesity and visual outcomes. J Neuroophthalmol. 2012 ; 33: 4-8
10. Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain. 1991 ; 114: 155-180
11. Sinclair AJ, Burdon MA, Nightingale PG, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: Prospective cohort study. BMJ. 2010 ; 341: c2701 - c2701
12. Barness LA, Opitz JM, Gilbert-Barness E. Obesity: Genetic, molecular, and environmental aspects. Am J Med Genet A. 2007 ; 143: 3016-3034
13. Cosar E, Cosar M, Köken G, et al. Polycystic ovary syndrome is related to idiopathic intracranial hypertension according to magnetic resonance imaging and magnetic resonance venography. Fertil Steril. 2008 ; 89: 1245-1246
14. Marcus DM, Lynn J, Miller JJ, et al. Sleep disorders: A risk factor for pseudotumor cerebri?. J Neuroophthalmol. 2001 ; 21: 121-123
15. Dave S, Longmuir R, Shah VA, et al. Intracranial hypertension in systemic lupus erythematosus. Semin Ophthalmol. 2008 ; 23: 127-133
16. Giuseffi V, Wall M, Siegel PZ, et al. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): A case-control study. Neurology. 1991 ; 41: 239-244
17. Blethen SL. Complications of growth hormone therapy in children. Curr Opin Pediatr. 1995 ; 7: 466-471
18. Friedman DI, Gordon LK, Egan RA, et al. Doxycycline and intracranial hypertension. Neurology. 2004 ; 62: 2297-2299
19. Fraunfelder FW, Fraunfelder FT, Corbett JJ. Isotretinoin-associated intracranial hypertension. Ophthalmology. 2004 ; 111: 1248-1250
20. Paciaroni M, Palmerini F, Bogousslavsky J. Clinical presentations of cerebral vein and sinus thrombosis. Front Neurol Neurosci. 2008 ; 23: 77-88
21. De Simone R, Ranieri A, Bonavita V. Advancement in idiopathic intracranial hypertension pathogenesis: Focus on sinus venous stenosis. Neurol Sci. 2010 ; 31: S33 - S39
22. Farb RI, Vanek I, Scott JN, et al. Idiopathic intracranial hypertension: The prevalence and morphology of sinovenous stenosis. Neurology. 2003 ; 60: 1418-1424
23. Riggeal BD, Bruce BB, Saindane AM, et al. Clinical course of idiopathic intracranial hypertension with transverse sinus stenosis. Neurology. 2013 ; 80: 289-295
24. Bono F, Giliberto C, Mastrandrea C, et al. Transverse sinus stenoses persist after normalization of the CSF pressure in IIH. Neurology. 2005 ; 65: 1090-1093
25. Rohr A, Bindeballe J, Riedel C, et al. The entire dural sinus tree is compressed in patients with idiopathic intracranial hypertension: A longitudinal, volumetric magnetic resonance imaging study. Neuroradiology. 2012 ; 54: 25-33
26. Stienen A, Weinzierl M, Ludolph A, et al. Obstruction of cerebral venous sinus secondary to idiopathic intracranial hypertension. Eur J Neurol. 2008 ; 15: 1416-1418
27. Bono F, Lupo MR, Lavano A, et al. MR venography of transverse sinuses in subjects with normal CSF pressure. Neurology. 2003 ; 61: 1267-1270
28. Biousse V, Bruce BB, Newman NJ. Update on the pathophysiology and management of idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry. 2012 ; 83: 488-494
29. De Simone R, Marano E, Fiorillo C, et al. Sudden re?opening of collapsed transverse sinuses and longstanding clinical remission after a single lumbar puncture in a case of idiopathic intracranial hypertension. Pathogenetic implications. Neurol Sci. 2005 ; 25: 342-344
30. Horev A, Hallevy H, Plakht Y, et al. Changes in cerebral venous sinuses diameter after lumbar puncture in idiopathic intracranial hypertension: A prospective MRI study. J Neuroimaging. 2013 ; 23: 375-378
31. Lee SW, Gates P, Morris P, et al. Idiopathic intracranial hypertension; immediate resolution of venous sinus "obstruction" after reducing cerebrospinal fluid pressure to<10cmH(2)O. J Clin Neurosci. 2009 ; 16: 1690-1692
32. Ahmed R, Friedman DI, Halmagyi GM. Stenting of the transverse sinuses in idiopathic intracranial hypertension. J Neuroophthalmol. 2011 ; 31: 374-380
33. Higgins JN, Cousins C, Owler BK, et al. Idiopathic intracranial hypertension: 12 cases treated by venous sinus stenting. J Neurol Neurosurg Psychiatry. 2003 ; 74: 1662-1666
34. Kumpe DA, Bennett JL, Seinfeld J, et al. Dural sinus stent placement for idiopathic intracranial hypertension. J Neurosurg. 2012 ; 116: 538-548
35. Fields JD, Javedani PP, Falardeau J, et al. Dural venous sinus angioplasty and stenting for the treatment of idiopathic intracranial hypertension. J Neurointerv Surg. 2013 ; 5: 62-68
36. Bussière M, Falero R, Nicolle D, et al. Unilateral transverse sinus stenting of patients with idiopathic intracranial hypertension. Am J Neuroradiol. 2010 ; 31: 645-650
37. Kesler A, Kliper E, Assayag EB, et al. Thrombophilic factors in idiopathic intracranial hypertension: A report of 51 patients and a meta-analysis. Blood Coagul Fibrinolysis. 2010 ; 21: 328-333
38. Jacobson DM, Berg R, Wall M, et al. Serum vitamin A concentration is elevated in idiopathic intracranial hypertension. Neurology. 1999 ; 53: 1114-1118
39. Selhorst JB, Kulkantrakorn K, Corbett JJ, et al. Retinol-binding protein in idiopathic intracranial hypertension (IIH). J Neuroophthalmol. 2000 ; 20: 250-252
40. Tabassi A, Salmasi AH, Jalali M. Serum and CSF vitamin A concentrations in idiopathic intracranial hypertension. Neurology. 2005 ; 64: 1893-1896
41. Libien J, Blaner WS. Retinol and retinol-binding protein in cerebrospinal fluid: Can vitamin A take the "idiopathic" out of idiopathic intracranial hypertension?. J Neuroophthalmol. 2007 ; 27: 253-257
42. Warner JEA, Bernstein PS, Yemelyanov A, et al. Vitamin A in the cerebrospinal fluid of patients with and without idiopathic intracranial hypertension. Ann Neurol. 2002 ; 52: 647-650
43. Warner JE, Larson AJ, Bhosale P, et al. Retinol-binding protein and retinol analysis in cerebrospinal fluid and serum of patients with and without idiopathic intracranial hypertension. J Neuroophthalmol. 2007 ; 27: 258-262
44. Kesler A, Kliper E, Shenkerman G, et al. Idiopathic intracranial hypertension is associated with lower body adiposity. Ophthalmology. 2010 ; 117: 169-174
45. Wozniak SE, Gee LL, Wachtel MS, et al. Adipose tissue: The new endocrine organ? A review article. Dig Dis Sci. 2009 ; 54: 1847-1856
46. Ooi LY, Walker BR, Bodkin PA, et al. Idiopathic intracranial hypertension: Can studies of obesity provide the key to understanding pathogenesis?. Br J Neurosurg. 2008 ; 22: 187-194
47. Ball AK, Sinclair AJ, Curnow SJ, et al. Elevated cerebrospinal fluid (CSF) leptin in idiopathic intracranial hypertension (IIH): Evidence for hypothalamic leptin resistance?. Clin Endocrinol (Oxf). 2009 ; 70: 863-869
48. Dhungana S, Sharrack B, Woodroofe N. IL-1beta, TNF and IP-10 in the cerebrospinal fluid and serum are not altered in patients with idiopathic intracranial hypertension compared to controls. Clin Endocrinol (Oxf). 2009 ; 71: 896-897
49. Wilsey J, Scarpace PJ. Caloric restriction reverses the deficits in leptin receptor protein and leptin signaling capacity associated with diet-induced obesity: Role of leptin in the regulation of hypothalamic long-form leptin receptor expression. J Endocrinol. 2004 ; 181: 297-306
50. Kim TW, Choung HK, Khwarg SI, et al. Obesity may not be a risk factor for idiopathic intracranial hypertension in Asians. Eur J Neurol. 2008 ; 15: 876-879
51. Wall M, Dollar JD, Sadun AA, et al. Idiopathic intracranial hypertension. Lack of histologic evidence for cerebral edema. Arch Neurol. 1995 ; 52: 141-145
52. Dhungana S, Waters P, Ismail A, et al. Absence of aquaporin-4 antibodies in patients with idiopathic intracranial hypertension. J Neuro. 2010 ; 257: 1211-1212
53. Kerty E, Heuser K, Indahl UG, et al. Is the brain water channel aquaporin-4 a pathogenetic factor in idiopathic intracranial hypertension? Results from a combined clinical and genetic study in a Norwegian cohort. Acta Ophthalmol. 2013 ; 91: 88-91
54. Lee AG, Golnik K, Kardon R, et al. Sleep apnea and intracranial hypertension in men. Ophthalmology. 2002 ; 109: 482-485
55. Rudnick E, Sismanis A. Pulsatile tinnitus and spontaneous cerebrospinal fluid rhinorrhea: Indicators of benign intracranial hypertension syndrome. Otol Neurotol. 2005 ; 26: 166-168
56. Friedman DI, Rausch EA. Headache diagnoses in patients with treated idiopathic intracranial hypertension. Neurology. 2002 ; 58: 1551-1553
57. Corbett JJ, Savino PJ, Thompson HS, et al. Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol. 1982 ; 39: 461-474
58. Wall M, White WN. Asymmetric papilledema in idiopathic intracranial hypertension: Prospective interocular comparison of sensory visual function. Invest Ophthalmol Vis Sci. 1998 ; 39: 134-142
59. Digre KB, Nakamoto BK, Warner JE, et al. A comparison of idiopathic intracranial hypertension with and without papilledema. Headache. 2009 ; 49: 185-193
60. Harder B, Jonas JB. Frequency of spontaneous pulsations of the central retinal vein. Br J Ophthalmol. 2007 ; 91: 401-402
61. Capobianco DJ, Brazis PW, Cheshire WP. Idiopathic intracranial hypertension and seventh nerve palsy. Headache. 1997 ; 37: 286-288
62. Agarwal P, Kumar M, Arora V. Clinical profile of cerebral venous sinus thrombosis and the role of imaging in its diagnosis in patients with presumed idiopathic intracranial hypertension. Indian J Ophthalmol. 2010 ; 58: 153-155
63. Arjona A, Delgado F, Fernandez?Romero E. Intracranial hypertension secondary to giant arachnoid granulations. J Neurol Neurosurg Psychiatry. 2003 ; 74: 418-418
64. Nimjee SM, Powers CJ, McLendon RE, et al. Single-stage bilateral choroid plexectomy for choroid plexus papilloma in a patient presenting with high cerebrospinal fluid output. J Neurosurg Pediatr. 2010 ; 5: 342-345
65. Lascaratos G, Ahmed S, Madill SA. Pearls & Oy-sters: Spontaneous venous pulsation and its role in differentiating papilledema from pseudopapilloedema. Neurology. 2010 ; 75: e53 - e54
66. Kurz-Levin MM, Landau K. A comparison of imaging techniques for diagnosing drusen of the optic nerve head. Arch Ophthalmol. 1999 ; 117: 1045-1049
67. Wallace IR, Mulholland DA, Lindsay JR. Diabetic papillopathy: An uncommon cause of bilateral optic disc swelling. QJM. 2012 ; 105: 583-584
68. Dandy WE. Intracranial pressure without brain tumor: Diagnosis and treatment. Ann Surg. 1937 ; 106: 492-513
69. Digre KB, Corbett JJ. Idiopathic intracranial hypertension (pseudotumor cerebri): A reappraisal. Neurologist. 2001 ; 7: 2-67
70. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013 ; 33: 629-808
71. Frisén L. Swelling of the optic nerve head: A staging scheme. J Neurol Neurosurg Psychiatry. 1982 ; 45: 13-18
72. Scott CJ, Kardon RH, Lee AG, et al. Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography vs clinical expert assessment using a clinical staging scale. Arch Ophthalmol. 2010 ; 128: 705-711
73. Agid R, Shelef I, Scott JN, et al. Imaging of the intracranial venous system. Neurologist. 2008 ; 14: 12-22
74. Roland T, Jacobs J, Rappaport A, et al. Unenhanced brain CT is useful to decide on further imaging in suspected venous sinus thrombosis. Clin Radiol. 2010 ; 65: 34-39
75. Ozsvath RR, Casey SO, Lustrin ES, et al. Cerebral venography: Comparison of CT and MR projection venography. Am J Roentgenol. 1997 ; 169: 1699-1707
76. Leach JL, Fortuna RB, Jones BV, et al. Imaging of cerebral venous thrombosis: Current techniques, spectrum of findings, and diagnostic pitfalls. Radiographics. 2006 ; 26: S19 - S41
77. Maralani PJ, Hassanlou M, Torres C, et al. Accuracy of brain imaging in the diagnosis of idiopathic intracranial hypertension. Clin Radiol. 2012 ; 67: 656-663
78. Ridha MA, Saindane AM, Bruce BB, et al. MRI findings of elevated intracranial pressure in cerebral venous thrombosis versus idiopathic intracranial hypertension with transverse sinus stenosis. Neuroophthalmol. 2013 ; 37: 1-6
79. Passi N, Degnan AJ, Levy LM. MR imaging of papilledema and visual pathways: Effects of increased intracranial pressure and pathophysiologic mechanisms. Am J Neuroradiol. 2013 ; 34: 919-924
80. Corbett JJ, Mehta MP. Cerebrospinal fluid pressure in normal obese subjects and patients with pseudotumor cerebri. Neurology. 1983 ; 33: 1386-1388
81. Rangwala LM, Liu GT. Pediatric idiopathic intracranial hypertension. Surv Ophthalmol. 2007 ; 52: 597-617
82. Whiteley W, Al-Shahi R, Warlow CP, et al. CSF opening pressure: Reference interval and the effect of body mass index. Neurology. 2006 ; 67: 1690-1691
83. Ragauskas A, Matijosaitis V, Zakelis R, et al. Clinical assessment of noninvasive intracranial pressure absolute value measurement method. Neurology. 2012 ; 78: 1684-1691
84. Wakerley B, Kusuma Y, Teoh HL, et al. Non-invasive intracranial pressure monitoring with transcranial Doppler in a patient with progressive cerebral venous sinus thrombosis. J Neuroimaging 2014; 24: 302-304.
85. Wakerley BR, Sharma VK. Transcranial Doppler derived pulsatility index in the assessment of intracranial pressure: The trend is your friend. Neurosurgery. 2013 ; 72: E319 - E320
86. Rowe FJ. Assessment of visual function in idiopathic intracranial hypertension. Br J Neurosurg. 2011 ; 25: 45-54
87. Chen JY, Taranath DA, Chappell AJ, et al. Objective monitoring of papilledema using confocal scanning laser ophthalmoscopy. Clin Experiment Ophthalmol. 2007 ; 35: 863-865
88. Kupersmith MJ, Gamell L, Turbin R, et al. Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology. 1998 ; 50: 1094-1098
89. McCarthy KD, Reed DJ. The effect of acetazolamide and furosemide on cerebrospinal fluid production and choroid plexus carbonic anhydrase activity. J Pharmacol Exp Ther. 1974 ; 189: 194-201
90. Celebisoy N, Gökçay F, Sirin H, et al. Treatment of idiopathic intracranial hypertension: Topiramate vs acetazolamide, an open-label study. Acta Neurol Scand. 2007 ; 116: 322-327
91. Shaikh AG, Bates JH, Yeates SW, et al. Fulminant idiopathic intracranial hypertension. JAMA Neurol. 2013 ; 70: 937-938
92. Huna-Baron R, Kupersmith MJ. Idiopathic intracranial hypertension in pregnancy. J Neurol. 2002 ; 249: 1078-1081
93. Badve M, McConnell MJ, Shah T, et al. Idiopathic intracranial hypertension in pregnancy treated with serial lumbar punctures. Int J Clin Med. 2011 ; 2: 9-12
94. Silberstein SD, Holland S, Freitag F, et al. Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012 ; 78: 1337-1345
95. Burgett RA, Purvin VA, Kawasaki A. Lumboperitoneal shunting for pseudotumor cerebri. Neurology. 1997 ; 49: 734-739
96. McGirt MJ, Woodworth G, Thomas G, et al. Cerebrospinal fluid shunt placement for pseudotumor cerebri-associated intractable headache: Predictors of treatment response and an analysis of long-term outcomes. J Neurosurg. 2004 ; 101: 627-632
97. Sinclair AJ, Kuruvath S, Sen D, et al. Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year review. Cephalalgia. 2011 ; 31: 1627-1633
98. Banta JT, Farris BK. Pseudotumor cerebri and optic nerve sheath decompression. Ophthalmology. 2000 ; 107: 1907-1912
99. Fridley J, Foroozan R, Sherman V, et al. Bariatric surgery for the treatment of idiopathic intracranial hypertension. J Neurosurg. 2011 ; 114: 34-39
100. Hernández-Díaz S, Smith CR, Shen A, et al. Comparative safety of antiepileptic drugs during pregnancy. Neurology. 2012 ; 78: 1692-1699
101. Chen TC, Chao CW, Sorkin JA. Topiramate induced myopic shift and angle closure glaucoma. Br J Ophthalmol. 2003 ; 87: 648-649
102. Matthews YY. Drugs used in childhood idiopathic or benign intracranial hypertension. Arch Dis Child Educ Pract Ed. 2008 ; 93: 19-25
103. Liu GT, Glaser JS, Schatz NJ. High-dose methylprednisolone and acetazolamide for visual loss in pseudotumor cerebri. Am J Ophthalmol. 1994 ; 118: 88-96
104. Puffer RC, Mustafa W, Lanzino G. Venous sinus stenting for idiopathic intracranial hypertension: A review of the literature. J Neurointerv Surg. 2013 ; 5: 483-486
105. Roberts RG, Redman JW. Indomethacin - a review of its role in the management of traumatic brain injury. Crit Care Resusc. 2002 ; 4: 271-280
106. Jensen K, Ohrström J, Cold GE, et al. The effects of indomethacin on intracranial pressure, cerebral blood flow and cerebral metabolism in patients with severe head injury and intracranial hypertension. Acta Neurochir (Wien). 1991 ; 108: 116-121
107. Rasmussen M. Treatment of elevated intracranial pressure with indomethacin: Friend or foe?. Acta Anaesthesiol Scand. 2005 ; 49: 341-350
108. Förderreuther S, Straube A. Indomethacin reduces CSF pressure in intracranial hypertension. Neurology. 2000 ; 55: 1043-1045
109. Spitze A, Malik A, Al-Zubidi N, et al. Optic nerve sheath fenestration vs cerebrospinal diversion procedures: What is the preferred surgical procedure for the treatment of idiopathic intracranial hypertension failing maximum medical therapy?. J Neuroophthalmol. 2013 ; 33: 183-188
110. Chumas PD, Kulkarni AV, Drake JM, et al. Lumboperitoneal shunting: A retrospective study in the pediatric population. Neurosurgery. 1993 ; 32: 376-383
111. Spoor TC, McHenry JG. Long-term effectiveness of optic nerve sheath decompression for pseudotumor cerebri. Arch Ophthalmol. 1993 ; 111: 632-635
112. Baheti NN, Nair M, Thomas SV. Long-term visual outcome in idiopathic intracranial hypertension. Ann Indian Acad Neurol. 2011 ; 14: 19-22
113. Ko MW, Chang SC, Ridha MA, et al. Weight gain and recurrence in idiopathic intracranial hypertension. Neurology. 2011 ; 76: 1564-1567
114. Malm J, Kristensen B, Markgren P, et al. CSF hydrodynamics in idiopathic intracranial hypertension: A long-term study. Neurology. 1992 ; 42: 851-858
115. Butros SR, Goncalves LF, Thompson D, et al. Imaging features of idiopathic intracranial hypertension, including a new finding: Widening of the foramen ovale. Acta Radiol. 2012 ; 53: 682-688
116. Schlosser RJ, Woodworth BA, Wilensky EM, et al. Spontaneous cerebrospinal fluid leaks: A variant of benign intracranial hypertension. Ann Otol Rhinol Laryngo. 2006 ; 115: 495-500
117. Kutz JW, Husain IA, Isaacson B, et al. Management of spontaneous cerebrospinal fluid otorrhea. Laryngoscope. 2008 ; 118: 2195-2199
118. Yang Z, Wang B, Wang C, et al. Primary spontaneous cerebrospinal fluid rhinorrhea: A symptom of idiopathic intracranial hypertension?. J Neurosurg. 2011 ; 115: 165-170
119. Pérez MA, Bialer OY, Bruce BB, et al. Primary spontaneous cerebrospinal fluid leaks and idiopathic intracranial hypertension. J Neuroophthalmol. 2013 ; 33: 327-334
120. Wall M. Idiopathic intracranial hypertension and the idiopathic intracranial hypertension treatment trial. J Neuro-Ophthalmol. 2013 ; 33: 1-3